✦ LIBER ✦

Experimental comparative studies with the new aromatase inhibitors CGS 16949 and CGS 20267

✍ Scribed by Bhatnagar, A.S.; Häusler, A.; Schieweck, K.; Lang, M.; Bowman, R.

Book ID: 121974921
Publisher: Elsevier Science
Year: 1990
Weight: 145 KB
Volume: 26
Category: Article
ISSN: 0277-5379
DOI: 10.1016/0277-5379(90)90334-P

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of Fadrozole (CGS 16949A) and Le

Effects of Fadrozole (CGS 16949A) and Letrozole (CGS 20267) on the inhibition of aromatase activity in breast cancer patients

✍ Laurence M. Demers 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 672 KB

Phase I study in healthy male volunteers

Phase I study in healthy male volunteers with the non-steroidal aromatase inhibitor CGS 20267

✍ Trunet, P.; Müller, Ph.; Bhatnagar, A.; Chaudri, H.; Beh, I.; Monnet, G. 📂 Article 📅 1990 🏛 Elsevier Science ⚖ 147 KB

Letrozole (CGS 20267). A phase I study o

Letrozole (CGS 20267). A phase I study of a new potent oral aromatase inhibitor of breast cancer

✍ Allan Lipton; Laurence M. Demers; Harold A. Harvey; Kathleen B. Kambic; Howard G 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 663 KB

In vitro and in vivo studies demonstrati

In vitro and in vivo studies demonstrating potent and selective estrogen inhibition with the nonsteroidal aromatase inhibitor CGS 16949A

✍ Ronald E. Steele; Lynn B. Mellor; Wilbur K. Sawyer; Jong M. Wasvary; Leslie J. B 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 878 KB

Effect of the potent aromatase inhibitor

Effect of the potent aromatase inhibitor fadrozole hydrochloride (CGS 16949A) in postmenopausal women with breast carcinoma

✍ Luis A. M. Costa; Michael S. Kopreski; Laurence M. Demers; Vernon M. Chinchilli; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB 👁 1 views

## Background: Fadrozole hydrochloride (cgs 16949a) is a highly potent, nonsteroidal aromatase inhibitor that significantly lowers estrogen levels in postmenopausal women and can be effective therapy for patients with advanced hormone-dependent breast carcinoma. circulating estradiol, estrone, and

In vitro potency and selectivity of the

In vitro potency and selectivity of the non-steroidal androgen aromatase inhibitor CGS 16949A compared to steroidal inhibitors in the brain

✍ Wozniak, A.; Holman, S.D.; Hutchison, J.B. 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 602 KB